Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Allium Medical promotes CFO to CEO

This article was originally published in Clinica

  • News
  • Girija Shettar

Executive Summary

Allium Medical (Caesarea, Israel), a developer and manufacturer of removable stents specially designed for the urinary and gastro-intestinal tract (see Medtech Ventures No 18 in Clinica No 1299) has promoted Limor Domnitz Gishri to CEO. Her successor as CFO is yet to be decided. Formerly CFO and vice-president of business, Ms Domnitz Gishri will now lead the company’s strategic growth plans. Her background is in law and accounting, where she specialised in advanced technologies and biotech. She currently combines her business responsibilities with lecturing in business and accounting at Tel Aviv University and College. Allium says Ms Domnitz Gishri has helped transform the company over two years from an R&D firm to a sales and distribution company.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

ICER Debuts Clinical Trial Diversity Assessment Framework

UK MHRA’s Strategic Approach To AI Will Be ‘Proportionate’ And Fit Well Internationally

Attorney: Proposed Data Privacy Law Would Ultimately Reduce Regulatory Burden

Senseonics Wins Marketing Authorization For Novel Insulin Delivery System

See All
UsernamePublicRestriction

Register

MT041973

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By